Abstract: The purpose of this study was to investigate possible circadian changes in extracellular concentrations of glutamate (GLU) and g-aminobutyric acid (GABA), and the influence of melatonin on the levels of these neurotransmitters in the neostriatum of awake rats using in vivo microdialysis. At the same time, the concentrations of the amino acids taurine (TAU), glutamine (GLN) and arginine (ARG), as well as dopamine (DA) and its metabolites 3, 4-dihydroxyphenyl acetic acid (DOPAC) and homovanillic acid (HVA), were measured in the extracellular fluid. When dialysates were collected over a 24-hr period (6 hr dark, 12 hr light, 6 hr dark), both GLU and GABA, without the infusion of melatonin, exhibited statistically significant rhythms, with higher levels of these constituents during the dark and lower levels during the day. Perfusion with melatonin (for 19 consecutive hours) prevented the daytime reductions in both GLU and GABA. Of the amino acids measured in the dialysates collected from the neostriatum of non-perfused rats, only ARG exhibited a significant change during the light:dark cycle; again, lowest concentrations were measured during the day. While melatonin perfusion did not statistically significantly influence neostriatal levels of TAU and ARG, GLN levels continued to drop during the infusion of the indoleamine. Dialysate concentrations of DA, DOPAC and HVA exhibited circadian rhythms which were not influenced by melatonin perfusion. The findings indicate there are differential effects of melatonin on extracellular neurotransmitter concentrations in the neostriatum of the awake rat. The results also suggest that the day:night variations in GLU and GABA may relate to daily changes in endogenous melatonin production, while DA and its metabolites are minimally influenced by this secretory product.
Introduction
Using microdialysis, extracellular concentrations of several neurotransmitters in the brain have been shown to display a circadian rhythm [Westerink 1995; Drijfhout et al., 1996; Honma et al., 1996] . Acetylcholine, for instance, exhibits light-dark variations in several cortical areas with an increase in its concentrations at night compared to daytime levels [Kametami and Kawamura, 1991; JimenezCapdeville and Dykes, 1993; Mitsushima et al., 1996] . Additional studies have also reported circadian variations for other neurotransmitters such as dopamine (DA) in the striatum [Smith et al., 1992] , noradrenaline in the pineal gland [Drijfhout et al., 1996; Miguez et al., 1998 ] and glutamate (GLU) and aspartate in the suprachiasmatic nuclei (SCN) [Honma et al., 1996] . That the circadian activity of certain neurotransmitters appears regionally specific is emphasized by the fact that DA exhibits a circadian rhythm in the striatum but not in the nucleus accumbens [Paulson and Robinson, 1994] .
GLU and g-aminobutyric acid (GABA) are two of the most abundant neurotransmitters in the central nervous system [Nicholls, 1993; De Lorey and Olsen, 1994] . Despite the important implications of these neurotransmitters in many physiological functions [Maragos et al., 1987; De Lorey and Olsen, 1994] as well as in the pathology of neurodegenerative disorders [Carlsson and Carlsson, 1990; Greenamyre, 1993; Segovia et al., 1999a] , few studies have investigated the possible circadian variation of these transmitters in specific areas of the brain. A recent report claimed a circadian rhythm of GLU in the SCN [Honma et al., 1996] . As for GABA, the number of the GABA-A receptors fluctuates with a maximun at night [Kanterewicz et al., 1995] . However, there are no reports related to the circadian changes of GLU and GABA in the striatum of the rat.
Over the past two decades, the effects of melatonin on a variety of physiologic and endocrine functions have been extensively studied [Reiter, 1991; Acuñ a-Castroviejo et al., 1995; Muñ ozHoyos et al., 1998 , Reiter, 1998 ]. In mammals, the secretion of melatonin by the pineal gland is believed to be a direct output of the circadian organization of the SCN [Cassone, 1990; Krause and Dubocovich, 1990] . Recently, it was shown that melatonin directly influences the electric and metabolic activity of the SCN and other neural areas as well [Krause and Dubocovich, 1990] . Despite considerable evidence for melatonin acting as a modulator of a variety of neural functions, little is known about the modulatory role of melatonin in terms of circadian variations of specific neurotransmitters [Reiter, 1989] or the interactions between neurotransmiters in specific areas of the brain [Expó sito et al., 1995a] .
The purposes of the present study were, first, to investigate the possible circadian changes in extracellular concentrations of GLU and GABA in the neostriatum of the awake rat, and then to examine the effects of melatonin on the circadian variations of these two neurotransmitters. Additionally, the circadian variations in the amino acids taurine (TAU), glutamine (GLN) and arginine (ARG), as well as the catecholamine DA and its metabolites 3,4-dihydroxyphenyl acetic acid (DOPAC) and homovanillic acid (HVA), were measured.
Materials and methods

Animals and surgery
Male Wistar rats (2 -3 months old, 250 -350 g weight) were housed in individual wire mesh cages, provided with food and water ad libitum, and mantained in a temperature-controlled room under a light:dark cycle of 12:12 (lights were off from 20.00-08:00 hr daily). All in vivo experiments, performed at the Universidad Complutense of Madrid, followed the guidelines of the International Council for Laboratory Animal Science (ICLAS).
Under Equithesin (2 mL/kg i.p.) anesthesia, bilateral guide cannulae were stereotaxically implanted into the neostriatum of the brain to accomodate microdialysis probes. The guide cannulae assembly [Segovia et al., 1997a,b] was then fixed to the skull by means of two anchorage screws and the application of dental cement. When inserted, the tip of the microdialysis probe was placed into the neostriatum: 0.6 mm rostral, 2.5 mm lateral to the bregma, and 2.8 mm ventral to the dura mater [Koning and Kippel, 1997] .
Ten to 15 days after surgery, microdialysis probes were inserted and experiments were performed in freely moving rats. Probes of concentric design were constructed in our own workshop with an active dialyzing length of 4 mm. The dialysis membrane had a molecular-weight cut-off of 5000 da (Hospal). The probes were perfused with artificial cerebro spinal fluid (CSF; composition in mM: NaCl, 137; CaCl 2 , 1.2; KCl, 3; MgSO 4 , 1; NaH 2 PO 4 , 0.5; Na 2 HPO 4 , 2; glucose, 3; pH =7.3) at a flow rate of 1.25 mL/min.
Once basal concentrations of amino acids and cathecolamines were established, 60-min samples were collected for 24 hr and immediately stored at −80°C until analysed. Experiments were conducted during a dark:light:dark cycle (Fig. 1A) . Changes in the perfusion medium during experiments were made by means of a liquid switch (Hamilton Apparatus, Nevada). Melatonin (500 mM) was perfused, beginning 1 hr before the light period and continued for the remainder of the experiment (Fig. 1B) . Melatonin (Sigma, St Louis, MO) was dissolved in CSF before infusion through the microdialysis probe. This was accomplished by a slight warming of the samples and with continuous stirring.
The microdialysis system (tubing and swivel) was filled with a dilute solution of benzolkonium chloride (armil) between experiments to prevent bacterial growth. At the end of the experiment, the animals were anesthetized with Equithesin and perfused intracardially with 0.9% saline solution followed by 10% formalin. The brain was removed and the placement of the microdialysis probe was verified after sectioning the brain with a cryostat microtome and viewing the section under a microscope.
Amino acid and catecholamine analysis
The amino acid content of the samples was analysed by reverse-phase high performance liquid chromatography (HPLC), with fluorometric detection by means of precolumn derivatization of 5 mL samples with an ophthalaldehyde solution, as described elsewhere [Segovia et al., 1997a ]. The detection limit in the 5 mL samples was 0.05 mM for all amino acids.
The catecholamine content of samples was analysed by reversed-phase HPLC and electrochemical detection [Segovia et al., 1997b] . Samples were injected in a Rheodyne injector (25 mL loop) running first in a C18 precolumn (Nova-Pack, Waters) and then in a C18 column of 4 mm particles, and 3.9 ×150 mm (Nova-Pack, Waters). The mobile phase consisted of 0.1 M acetate-citrate buffer (pH=3.5 adjusted with HCl 1 equ/L), 1 mM EDTA, 2.9 mM sodium octyl sulphonate, and 18% methanol. The flow rate was maintained at 1 mL/min. These conditions allowed DA to be detected within 4 min. Melatonin disrupted the chromatographic analysis of DA; therefore, DA was not measured in these experiments.
Catecholamines were mesaured using a coulometric detector (Coulochem II model 5200A, ESA, MA). A conditioning cell (ESA 5021) was set at +50 mV and analytical cell (ESA 5011) was set at +340 mV (cell 1) and at − 250 mV (cell 2). Chromatograms were processed using the Maxima 820 (Waters, CA) software. The detection limit in the 25 mL samples was 0.2 nM for DA.
Statistical analysis
Data are reported as absolute dialysate concentrations. Repeated measure ANOVAs, following linear regresion analysis, were used to study the variations of the dialysate concentrations in the dark-light and light-dark transitions.
Results
Basal dialysate concentrations of amino acids found in neostriatum of the rat were (in mM, mean9S.E.M.; n = 4): GLU = 0.549 0.05; Dialysate concentrations of GLU and GABA showed circadian variations in the neostriatum of the awake rat. GLU decreased by 37% during the light period (n=4; P B0.0001) and increased (n =4; PB0.01) during the following period of darkness ( Fig. 2A) . GABA decreased by 19% during the light period (n=4; P B0.0001) and rose to 100% of basal values at night (Fig. 2B) . Dialysate concentrations of GLN and TAU showed no circadian variations (Fig. 2C, D) .
Dialysate concentrations of ARG exhibited a circadian rhythm in the neostriatum, decreasing by 29% during the light period (n=4; P B0.001) and rising to 82% of the basal values during the following dark period (n =4; P B0.01) (Fig. 2E) .
Dialysate concentrations of DA and its metabolites, DOPAC and HVA, showed circadian variations in the neostriatum. DA decreased by 37% during the light period (n= 4; P B0.05) and increased to 139% of the basal values (n =4; PB 0.05) during the following dark period (Fig. 3A) . DOPAC decreased by 25% during the light period (n =4; PB0.0001) relative to the previous dark period (n=4; PB0.0001) (Fig. 3B) . HVA decreased in the light period by 18% (n=4; PB 0.0001) and increased to 119% of the basal values in the following period of darkness (n=4; PB 0.0001) (Fig. 3C) .
Perfusion of melatonin (500 mM) into the neostriatum during the light and following dark period disrupted the circadian variations of GLU and significant variations during the 24-hr cycle when melatonin was perfused (Fig. 4B) .
Melatonin induced a decrease of the dialysate concetrations of GLN to 21% of the basal values (n =4; P B0.0001) during the light and the second dark period (Fig. 4 C) . During this latter period of darkness, GLN continued decreasing at the same time that GLU levels increased (Fig. 4 A and C,  respectively) . Melatonin did not change the dialysate concentrations of TAU (Fig. 4D) . From the beginning of the light period to the end of the following dark period, ARG decreased to 11% of the basal concentrations when melatonin was infused (Fig. 4E) .
Dialysate concentrations of DA metabolites, DOPAC and HVA, were not affected by melatonin perfusion. DOPAC decreased by 75% during the light period (n=4; PB0.0001) and did not change during the following period of darkness (Fig. 5A) . HVA decreased during the period of light by 79% (n=4; P B0.0001) and increased by 69% of the basal values (n=4; PB 0.0001) during the following dark period (Fig. 5B) . GABA. Dialysate concentrations of GLU showed no reduction during the light period but increased to 896% of the basal values during the second period of darkness (n =4; P B0.0001) (Fig. 4A) . Dialysate concentrations of GABA showed no crease of concentrations during the light phase compared to the dark phase. These results also show a circadian variation of extracellular concentrations of DA and its metabolites, DOPAC and HVA, as previously described [Nakayama et al., 1993; Paulson and Robinson, 1994; Shieh et al., 1997] . Also ARG showed a similar circadian variation. Melatonin, intracerebrally perfused, produced a disruption of the circadian variations of GLU, GABA, and ARG, but not of DOPAC and HVA. TAU, which showed no differences across the 24-hr period, did not change during melatonin infusion. Extracellular levels of GLN, which also showed no circadian variations, were significantly reduced during melatonin perfusion. The findings suggest that melatonin causes differential responses in the neurotransmitter studied.
Circadian variations of GLU and GABA in the neostriatum have not been reported previously. However, a circadian variation of GLU has been noted in the SCN [Honma et al., 1996] . Since both neurons and astrocytes contribute to the extracellular concentrations of GLU and GABA, it is possible that the circadian variations found for these two neurotransmitters involved the activities of both cell types. In fact, circadian changes in astrocytes have been reported suggesting that an activation of glia cells occurs during the light period [Lavialle and Servière, 1993] . This suggestion is consistent with astrocytes being primarily responsible for controlling extracellular concentra- 
Discussion
The results show, for the first time, that circadian rhythms for extracellular concentrations of GLU and GABA exist in the neostriatum, with a de-tions of GLU [Rothstein et al., 1996] . It is possible that the similar mechanisms may account for the decrease in extracellular GABA concentrations found during the light phase; this may relate to the presence of high affinity transporters for GABA in astrocytes [Kanner, 1997] .
To our knowledge, a circadian rhythm of ARG has not previously been reported. Since ARG is the metabolic precursor of nitric oxide (NO), the possibility exists that ARG cyclicity reflects the activity of the synthesis of NO in the neostriatum. Both in vitro and in vivo studies have shown that NO modulates DA, GLU, and GABA in neostriatum [Segovia and Mora, 1998 ], and these neurotransmitters, as we have shown in the present study, exhibit circadian changes in this area. It is plausible, therefore, that NO also changes in a circadian manner in the neostriatum. In a recent study, Bettahi et al. [1996] showed that hypothalamic NO synthase activity decreased during the dark period. On the contrary, Burlet and Cespuglio [1997] found, in the cortex, high NO levels during wakefulness (dark period] and decreased levels during sleep (light period). Further studies are required to investigate the possible circadian activity for NO in specific areas of the brain.
Regarding the circadian variations in extracellular DA, DOPAC, and HVA in the neostriatum, as shown here, they are in agreement with previous studies [Nakayama et al., 1993; Paulson and Robinson, 1994; Shieh et al., 1997] . It has been suggested that these variations are related to changes in neuronal activity (the nigrostriatal-DA system) produced in the neostriatum as a result of the locomotor activity of the animals [Paulson and Robinson, 1994] .
That the effects of melatonin on GABA and GLU may be specifically related to the interaction of melatonin with these neurotransmitters is indirectly suggested by the fact that both the DOPAC and HVA rhythms were unaltered, while those of GLN and ARG were reduced by melatonin. Moreover, TAU was unaffected by melatonin perfusion.
Melatonin may play a modulatory role in influencing various neurotransmitters in the central nervous system. An interaction between melatonin and DA in the anterior hypothalamus has been noted [Zisapel et al., 1987; Krause and Dubocovich, 1990; Expó sito et al., 1995a] . We have shown that melatonin modulates the action of DA on GLU levels in the hypothalamus and that this effect does not occur in other brain areas, e.g. parieto-temporal cortex [Expó sito et al., 1995b] . Also, a change in the DA -GLU interactions induced by melatonin in the hypothalamus during aging has been reported [Expó sito et al., 1995b] .
Few studies have investigated the influence of melatonin on neurotransmitter levels, particularly GLU and GABA, during the light period of the 24-hr cycle [Reiter, 1993] . It would be expected that if extracellular concentrations of melatonin are high during the dark period, and that the indole alters circadian rhythmicity of some neurotransmitters, such as GLU and GABA, the artificial infusion of melatonin during the light period would disrupt these rhythms. Thus, perhaps perfusion of melatonin during the light phase would prolong the endogenous effects of melatonin produced during the dark period. That is, in fact, what was observed for GLU and GABA, but not for the DA metabolites, DOPAC and HVA.
It is interesting that the effects of melatonin that exhibited an increase in GLU coincided in time with the decrease in GLN. As stated above, GLN, mainly synthesized in astrocytes, is the major metabolic precursor for GLU in neurons [Segovia et al., 1999b] . Therefore, the change observed could be due to GLN being used for the synthesis and release of GLU during the dark phase. These effects of melatonin suggest that the circadian activity of GLU is related to functional interaction between neurons and glia and that melatonin may have some direct effects on astrocytes.
It is assumed that the effects of melatonin on the neurotransmitters reported herein were mediated by melatonin receptors located in the cell membranes of either neurons or glia [Chabot et al., 1998; Lapin et al., 1998; Kaur and Ling, 1999] . On the other hand, presumed melatonin receptors have also been found in the nuclei of brain cells [Carlberg and Wiesenberg, 1995] . Finally, the direct free-radical scavenging actions of melatonin require no receptors [Reiter, 1998 ], but it seems these actions of melatonin were not involved in the actions reported here.
The present studies show differential effects of melatonin on different neurotransmitter systems in the neostriatum of the awake rat. The findings also suggest that the diurnal rhythms of GLU and GABA in the neostriatum may be, in part, dependent on melatonin, and that DA metabolites are only influenced by the presence of melatonin in a minor way. 
